NDA 205175 · Resilia Pharms
Ecoza
Econazole Nitrate · Topical
Last checked: Nov 19, 2026Latest source record: Nov 18, 2019 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
2013
Oct 24, 2013
Approved uses
1
Original approval plus efficacy supplements
Registered trials
8
3 Phase 3, 0 recruiting
FAERS reports
947
615 serious, 57 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect Oct 31, 2025.
Econazole nitrate topical foam, 1%, is indicated for the treatment of interdigital tinea pedis caused by Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum in patients 12 years of age and older. Econazole nitrate is an azole antifungal indicated for the treatment of interdigital tinea pedis caused by Trichophyton rubrum, Trichophyton mentagrophytes , and Epidermophyton floccosum in patients 12 years of age and older. ( 1 )
Mechanism: Econazole nitrate topical foam is an azole antifungal [ see Clinical Pharmacology (12.4) ] .
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Oct 24, 2013 Original approval · Type 3 - New Dosage Form LabelPediatric Statistical ReviewPediatric Medical Review
1 products under this application
- ECOZA · ECONAZOLE NITRATE 1% · AEROSOL, FOAM, TOPICAL · Prescription
Clinical trials
Interventional ClinicalTrials.gov studies with "Econazole Nitrate" as an intervention, any sponsor and status, largest first.
- Therapeutic Equivalence and Safety of Two Econazole Nitrate Cream, 1% Products in Tinea PedisPivotal-lookingCompleted
Mylan Inc.Industry
NCT03129321 · 876 participants · Start Mar 15, 2016 · Primary completion Nov 17, 2016
Drug: Econazole Nitrate Cream, 1%; Placebo · For: Tinea Pedis
- Safety and Efficacy of Econazole Nitrate Foam 1% and Foam Vehicle in Subjects With Tinea PedisPivotal-lookingCompleted
AmDermaIndustry
NCT01358240 · 336 participants · Start Jun 2011 · Primary completion Apr 2012
Drug: Econazole Nitrate Foam 1%; Vehicle Foam and 1 more · For: Tinea Pedis; Athlete's Foot
Sites: Fremont, California; Hockessin, Delaware; Boca Raton, Florida · 12 sites in all
- Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea PedisPivotal-lookingCompleted
AmDermaIndustry
NCT01353976 · 264 participants · Start May 2011 · Primary completion Apr 2012
Drug: Econazole Nitrate Foam 1% · For: Tinea Pedis; Athlete's Foot
Sites: Miramar, Florida; Clinton Township, Michigan; Las Vegas, Nevada · 7 sites in all
- A Study of Econazole Foam 1% in Athlete's FootPivotal-lookingCompleted
AmDermaIndustry
NCT00768599 · 135 participants · Start Mar 2008 · Primary completion Sep 2008
Drug: Econazole Nitrate Cream 1%; Econazole Nitrate Foam 1% and 1 more · For: Tinea Pedis; Athlete's Foot
Sites: San Diego, California; Clinton Township, Michigan; Fridley, Minnesota · 6 sites in all
- Tolerability and Pharmacokinetic Study of Econazole Nitrate Plus Benzydamine HCl Vaginal PessaryCompleted
Aziende Chimiche Riunite Angelini Francesco S.p.AIndustry
NCT02720783 · 49 participants · Start Mar 4, 2016 · Primary completion Oct 12, 2016
Drug: Econazole nitrate 150 mg plus Benzydamine HCl 6 mg vaginal pessary; Placebo plus Econazole nitrate 150 mg vaginal pessary and 2 more · For: Healthy Women
Sites: Arzo, Switzerland
- Tolerability and Pharmacokinetic Study of Econazole Nitrate and Benzydamine HCl Intravaginal CreamCompleted
Aziende Chimiche Riunite Angelini Francesco S.p.AIndustry
NCT02713893 · 48 participants · Start Sep 2015 · Primary completion Jun 2016
Drug: Econazole nitrate 1% plus Benzydamine HCl 0.12% intravaginal cream; Placebo plus Econazole nitrate 1% intravaginal cream and 2 more · For: Healthy
Sites: Arzo, Switzerland
AmDermaIndustry
NCT01696799 · 42 participants · Start Sep 2011 · Primary completion Apr 2012
Drug: Econazole Nitrate; placebo · For: Interdigital Tinea Pedis
Sites: San Diego, California
Abeona Therapeutics, IncIndustry
NCT00385502 · 40 participants · Start Sep 2006 · Primary completion Jun 2008
Drug: EcoNail™ (econazole 5%/SEPA® 18% nail lacquer) · For: Onychomycosis
Sites: Tucson, Arizona; New York, New York; Portland, Oregon
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- fatigue63
- drug ineffective59
- rash50
- dyspnoea48
- nausea48
- pain47
- diarrhoea45
- dizziness41
- asthenia39
- headache39
- pruritus39
- renal failure38
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 8 |
| 2005 | 9 |
| 2006 | 13 |
| 2007 | 19 |
| 2008 | 21 |
| 2009 | 28 |
| 2010 | 18 |
| 2011 | 34 |
| 2012 | 33 |
| 2013 | 35 |
| 2014 | 15 |
| 2015 | 62 |
| 2016 | 64 |
| 2017 | 74 |
| 2018 | 79 |
| 2019 | 64 |
| 2020 | 73 |
| 2021 | 48 |
| 2022 | 40 |
| 2023 | 53 |
| 2024 | 49 |
| 2025 | 57 |
| 2026 | 51 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Athlete's foot.
Crawford F · BMJ Clin Evid 2009 · Systematic Review
- Improved bioequivalence assessment of topical dermatological drug products using dermatopharmacokinetics.
N'Dri-Stempfer B, Navidi WC, Guy RH, et al. · Pharm Res 2009 · Clinical Trial, Comparative Study
- Econazole Nitrate Foam 1% Improves the Itch of Tinea Pedis.
Fleischer AB, Raymond I · J Drugs Dermatol 2016 · Clinical Trial, Phase III, Multicenter Study
- Pityrosporum (Malassezia) folliculitis in Saudi Arabia--diagnosis and therapeutic trials.
Abdel-Razek M, Fadaly G, Abdel-Raheim M, et al. · Clin Exp Dermatol 1995 · Clinical Trial, Controlled Clinical Trial
- Efficacy of twice-daily dosing of econazole nitrate 1% cream for tinea pedis.
Brenner M · J Am Podiatr Med Assoc 1990 · Clinical Trial
- Follow-up study after more than one year including 100 patients treated for superficial mycoses.
Grigoriu D, Pallarés JL · Dermatologica 1980 · Clinical Trial, Controlled Clinical Trial
Sponsor: Resilia Pharms
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.